| MHC class I antigens, immune surveillance, and tumor immune escape A Garcia‐Lora, I Algarra, F Garrido Journal of cellular physiology 195 (3), 346-355, 2003 | 467 | 2003 |
| The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape I Algarra, A García-Lora, T Cabrera, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 53 (10), 904-910, 2004 | 312 | 2004 |
| MHC antigens and tumor escape from immune surveillance F Garrido, I Algarra Academic Press 83, 117-158, 2001 | 301 | 2001 |
| The HLA crossroad in tumor immunology I Algarra, T Cabrera, F Garrido Human immunology 61 (1), 65-73, 2000 | 217 | 2000 |
| A new extract of the plant Calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation E Jiménez-Medina, A Garcia-Lora, L Paco, I Algarra, A Collado, F Garrido BMC câncer 6 (1), 119, 2006 | 211 | 2006 |
| Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen‐receptor status and predicts for poor prognosis JJ Gaforio, MJ Serrano, P Sanchez‐Rovira, A Sirvent, ... International journal of cancer 107 (6), 984-990, 2003 | 150 | 2003 |
| MHC class I antigens and immune surveillance in transformed cells N Aptsiauri, T Cabrera, A Garcia‐Lora, MA Lopez‐Nevot, F Ruiz‐Cabello, ... International review of cytology 256, 139-189, 2007 | 138 | 2007 |
| The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis E Jiménez-Medina, E Berruguilla, I Romero, I Algarra, A Collado, ... BMC cancer 8 (1), 78, 2008 | 97 | 2008 |
| MHC class I‐deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components A Garcia‐Lora, M Martinez, I Algarra, JJ Gaforio, F Garrido International journal of cancer 106 (4), 521-527, 2003 | 94 | 2003 |
| The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions F Garrido, I Algarra, AM García-Lora Cancer immunology, immunotherapy 59 (10), 1601-1606, 2010 | 88 | 2010 |
| Immunoselection by T lymphocytes generates repeated MHC class I‐deficient metastatic tumor variants A Garcia‐Lora, I Algarra, JJ Gaforio, F Ruiz‐Cabello, F Garrido International journal of cancer 91 (1), 109-119, 2001 | 85 | 2001 |
| Altered MHC class I antigens in tumors I Algarra, A Collado, F Garrido International Journal of Clinical and Laboratory Research 27 (2-4), 95-102, 1997 | 76 | 1997 |
| Tumour immunology, vaccination and escape strategies A García‐Lora, I Algarra, A Collado, F Garrido European journal of immunogenetics 30 (3), 177-183, 2003 | 72 | 2003 |
| Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations N Aptsiauri, R Carretero, A Garcia-Lora, LM Real, T Cabrera, F Garrido Cancer Immunology, Immunotherapy 57 (11), 1727, 2008 | 68 | 2008 |
| MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells C Garrido, L Paco, I Romero, E Berruguilla, J Stefansky, A Collado, ... Carcinogenesis 33 (3), 687-693, 2012 | 63 | 2012 |
| HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank R Mendez, N Aptsiauri, A Del Campo, I Maleno, T Cabrera, ... Cancer immunology, immunotherapy 58 (9), 1507-1515, 2009 | 53 | 2009 |
| Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor. A Garrido, M Perez, C Delgado, ML Garrido, J Rojano, I Algarra, F Garrido Experimental and clinical immunogenetics 3 (2), 98-110, 1986 | 49 | 1986 |
| Metastases in immune-mediated dormancy: a new opportunity for targeting cancer I Romero, F Garrido, AM Garcia-Lora Cancer research 74 (23), 6750-6757, 2014 | 48 | 2014 |
| Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line A García-Lora, M Martinez, S Pedrinaci, F Garrido Cancer Immunology, Immunotherapy 52 (1), 59-64, 2003 | 47 | 2003 |
| NK sensitivity and lung clearance of MHC‐class‐I‐deficient cells within a heterogeneous fibrosarcoma I Algarra, C Ohlén, M Perez, HG Ljunggren, G Klein, F Garrido, K Karre International journal of cancer 44 (4), 675-680, 1989 | 44 | 1989 |
